Monitoring and Management of Toxicities in Long-Term Thiopurine Therapy

by Keyashian, Kian
Published 2013

Novel Topics in Inflammatory Bowel Disease

by Sakuraba, Atsushi, Armuzzi, Alessandro, Keyashian, Kian, Naganuma, Makoto
Published in Biomed Res Int (2016)

Prevalence of Antibodies Against JC Virus in Serum of Patients With Refractory Crohn’s Disease and Effects of Natalizumab Therapy

by Bellaguarda, Emanuelle, Keyashian, Kian, Pekow, Joel, Rubin, David T., Cohen, Russell D., Sakuraba, Atsushi
Published in Clin Gastroenterol Hepatol (2015)

Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States

by Keyashian, Kian, Dehghan, Melody, Sceats, Lindsay, Kin, Cindy, Limketkai, Berkeley N, Park, K T
Published in Inflamm Bowel Dis (2019)

Natalizumab in Crohn’s Disease: Results from a US tertiary IBD center

by Sakuraba, Atsushi, Keyashian, Kian, Correia, Chase, Melek, John, Cohen, Russell D., Hanauer, Stephen B., Rubin, David T.
Published in Inflamm Bowel Dis (2013)

Risk of Postoperative Surgical Site Infections after Vedolizumab versus Anti-Tumor Necrosis Factor Therapy: A Propensity-Score Matching Analysis in Inflammatory Bowel Disease

by Park, KT, Sceats, Lindsay, Dehghan, Melody, Trickey, Amber W., Wren, Anava, Wong, Jessie J., Bensen, Rachel, Limketkai, Berkeley N., Keyashian, Kian, Kin, Cindy
Published in Aliment Pharmacol Ther (2018)